Forty years have passed since the landmark publication on the importance of Helicobacter pylori as a triggering factor for gastritis by Warren and Marshall. In that time, the understanding of associations between H. pylori infection of the gastric mucosa with both inflammatory and malignant diseases of the stomach and extragastric diseases has grown steadily. In 2022, the fourth version of the S2k guideline “Helicobacter pylori and gastroduodenal ulcer disease” of the German Society for Digestive and Metabolic Diseases was published. The most relevant innovations are summarized here briefly, concisely and clinically applicable.
This content is machine-translated. Please contact us if you need professional translation services.
Autoren
- PD Dr. med. Kerstin Schütte
- PD Dr. med. Christian Schulz
Publikation
- GASTROENTEROLOGIE PRAXIS
Related Topics
You May Also Like
- Journal Club
Atopic dermatitis and the skin microbiome: new study findings
- AID systems for type 1 diabetes
New real-world data shows: AI makes the difference
- Derma-oncology
Current study results underline the risk of skin cancer
- Vaccines against pneumococci, influenza & RSV
Avoid exacerbations with the vaccination
- Rehospitalization
Analysis of unplanned readmissions to acute care hospitals.
- Suspicion of coronary heart disease
Stress echocardiography, MR heart or computed tomography heart?
- Cardiorenal syndrome
Cross-talk between heart and kidney
- Chronic urticaria